Ivermectin
(asked on 24th June 2021) - View Source
Question to the Department of Health and Social Care:
To ask Her Majesty's Government whether Ivermectin is being considered to treat mild cases of COVID-19.
This question was answered on 6th July 2021
On 23 June, the PRINCIPLE clinical trial platform in the United Kingdom announced that ivermectin would be investigated to generate robust data on its effectiveness in treating adults aged 18 years old and over with mild COVID-19 who are at higher risk of developing serious illness. We will closely monitor the data from this trial, as well as emerging clinical trials worldwide to expand our evidence-base on the efficacy of ivermectin in treating COVID-19.